MDA accelerates the glomerular mesangial cell apoptosis through inhibition of Nrf 2/ARE
- VernacularTitle:丙二醛通过抑制Nrf2／ARE促进肾小球系膜细胞凋亡
- Author:
Lu ZHAO
;
Junbo SUN
;
Xiaoqin JING
- Publication Type:Journal Article
- Keywords:
malondialdehyde;
diabetic nephropathy;
glomerular mesangial cell;
ROS;
Nrf2
- From:
Basic & Clinical Medicine
2015;(1):69-73
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the function of MDA on diabetic nephropathy .Methods Glomerular mesangial cells ( GMC) were pretreated with MDA at a final concentrations of 0μmol/L, 1μmol/L, 5μmol/L, 10μmol/L and 50 μmol/L.MTT assay was used to examine the viability of GMC ) .AnnexinV-FITC was used to evaluate effect of MDA on cell apoptosis .RT-PCR and western blot were used to analyze the expression of Nrf 2, HO-1 andγGCL.Results MDA treatment inhibited GMC viability in a dose-dependent manner .MDA at the concentration of more than 5 μmol/L induced mass production of ROS in GMC ( P<0.05 ) .In addition , antioxygen of tBHQ may relieve MDA-induced reduction of cell viability .MDA inhibited the expression of HO-1 , γGCLand Nrf2 ( P <0.05 ) .Conclusions MDA inhibites GMC viability and promotes the cell apoptosis by ROS production through in-hibiting Nrf2/HO-1-γGCL.
